Healthcare >> CEO Interviews >> October 5, 2000
EVAN JONES is Chairman & CEO of Digene Corporation. He served as
President and CEO of Digene from July 1990 to July 1999. From 1988 to
September 1990, Mr. Jones served as President of Neomorphics, Inc., a
Boston area company specializing in transplantation technologies.
Between 1987 and 1990, he was first an Associate and then a Partner with
the CW Group, a healthcare venture capital firm. From 1983 to 1987, Mr.
Jones was employed by Perkin-Elmer Corporation, a biotechnology supply
company, ultimately serving as Worldwide Biotechnology Marketing
Manager. He received a BA in Biochemistry from the University of
Colorado and an MBA from the Wharton School, University of Pennsylvania. Profile
Mr. Jones: Digene is a leader in the gene-testing business. We went
public in 1996. Our products are based on the Hybrid Capture Gene
Analysis System.
